sunesis pharmaceuticals inc
(RYIN:Frankfurt)
Executive Profile*
Eric H. BjerkholtChief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary, Sunesis Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 8 board members in 1 different organizations across 3 different industries. See Board Relationships |
| 52 | $672,554 As of Fiscal Year 2012 |
Background*
Mr. Eric H. Bjerkholt has been Chief Financial Officer of Sunesis Pharmaceuticals Inc. since January 2004 and as its Executive Vice President of Corporate Development & Finance since February 2, 2012. Mr. Bjerkholt also serves as Principal Accounting Officer and Secretary of Sunesis Pharmaceuticals Inc. and previously served as its Senior Vice President of Corporate Development and Finance since February 2007. Mr. Bjerkholt has several years of experience and expertise ...
Corporate Headquarters*395 Oyster Point BoulevardSouth San Francisco, California 94080 United States Phone: 650-266-3500 Fax: 650-266-3501 Board Members Memberships*2004-Present Director, Chairman of Audit Committee, Member of Compensation & Stock Option Committee and Member of Strategic Transactions Committee
Education*MBA Harvard Business School Bachelor's Degree Oslo and Akershus University College of Applied Sciences
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| RYIN:GR | €4.17 EUR | -0.081 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Robert W. Cook | Interim Chief Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance & Administration, Secretary and Director EpiCept Corporation | $326.2K |
| John R. Plachetka Pharm D. | Co-Founder, Chairman of the Board, Chief Executive Officer and President POZEN Inc. | $574.5K |
| Ronald A. Martell | Chief Executive Officer, President and Director NeurogesX, Inc. | -- |
| Mark A. Sirgo Pharm.D. | Chief Executive Officer, President, Chief Scientific Officer, Executive Director, Member of Executive Subcommittee and Member of Risk Management Committee BioDelivery Sciences International, Inc. | $620.5K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
